Turing Biosystems develops software that analyzes clinical and biological data to design treatments for patients.
Turing Biosystems has raised $1.4M in total funding. The most recent round was Seed. The last funding was announced in October 2024.
Turing Biosystems's investors include Haatch, Creator Fund, January Ventures, another.vc.
Turing Biosystems is headquartered in London, United Kingdom.
Turing Biosystems develops software that analyzes clinical and biological data to design treatments for patients.
Turing Biosystems is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Turing Biosystems — Funding & Investors." VCBacked, October 28, 2024, https://www.vcbacked.co/company/turing-biosystems. Accessed September 29, 2026.
VCBacked. (2024). Turing Biosystems — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/turing-biosystems
{{cite web |title=Turing Biosystems — Funding & Investors |url=https://www.vcbacked.co/company/turing-biosystems |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated